L-carnitine Enantiomer Separation via Selective Crystallization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing highly pure L-carnitine from enantiomeric mixtures are complex, labor-intensive, and costly, often requiring optically active auxiliary agents and multiple steps, especially when using non-microbiological processes.
Innovation Solution
A method involving a solution of D- and L-carnitine in a first solvent, optionally seeded with L-carnitine crystals, followed by the addition of a second solvent in which L-carnitine has low solubility, leading to crystallization and isolation of highly pure L-carnitine crystals without the need for optically active agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If non-microbiological organic synthesis is used to produce L-carnitine, then production capacity can be scaled up, but a mixture of D- and L-carnitine is obtained requiring complex separation
Solution Approach 1:
The invention changes the physical-chemical parameters of the system by using a specific solvent mixture (first solvent in which L-carnitine is soluble, second solvent in which it is insoluble or has low solubility) to induce preferential crystallization of L-carnitine from the racemic mixture, thereby achieving high enantiomeric purity through controlled solubility parameters rather than complex chemical separation
Solution Approach 2:
The invention extracts L-carnitine from the racemic mixture through selective crystallization. By adding the second solvent to the solution containing the racemic mixture, L-carnitine is selectively extracted in crystalline form while D-carnitine remains in the mother liquor, achieving separation without complex auxiliary agents
2Manufacturing precision
If optically active auxiliary agents are used for separating L- and D-carnitine, then enantiomeric purity can be achieved, but the process becomes more complicated and costly
Solution Approach 1:
The invention completely eliminates the need for optically active auxiliary agents by using direct selective crystallization. The separation is achieved by exploiting the inherent solubility differences between L-carnitine and the solvent system, removing the complexity of adding, reacting with, and subsequently removing auxiliary separation agents
Solution Approach 2:
The L-carnitine molecules themselves serve the separation function through their inherent crystallization properties. The process uses the natural tendency of L-carnitine to crystallize selectively from the specific solvent system, without requiring external auxiliary agents to facilitate the separation
3Manufacturing precision
If optically active auxiliary agents are used for separation, then L- and D-carnitine can be separated, but additional steps for adding and removing the separating agent are required
Solution Approach 1:
The invention extracts L-carnitine directly from the racemic mixture through selective crystallization induced by the second solvent. This eliminates the time-consuming steps of adding auxiliary agents, performing separation reactions, and subsequently removing the agents, reducing the overall process time to a single crystallization and filtration operation
Solution Approach 2:
The invention skips the intermediate steps of using auxiliary separation agents entirely. By directly inducing selective crystallization with the second solvent, the process rushes through to the final separation in one efficient operation, eliminating multiple sequential steps and reducing total process time
4Manufacturing precision
If recrystallization with multiple solvents is used to remove impurities, then purity can be improved, but the process becomes more complex and labor-intensive
Solution Approach 1:
The invention merges the separation of enantiomers and the removal of impurities into a single selective crystallization step. By carefully selecting the first and second solvents, the process achieves both enantiomeric separation and impurity removal simultaneously, eliminating the need for multiple sequential recrystallization operations
Solution Approach 2:
The invention uses specific solvent parameters (solubility characteristics of L-carnitine in the first solvent and insolubility/low solubility in the second solvent) to achieve both enantiomeric separation and impurity removal in one operation. The parameter optimization of the solvent system allows simultaneous achievement of multiple purification goals without increasing operational complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method significantly increases enantiomeric purity and yield of L-carnitine, reducing the number of process steps and costs, while maintaining a simple and efficient process for producing highly pure L-carnitine.
Implementation Method 1
adding a second solvent, in which the L-carnitine is not soluble or has a low solubility, (c) isolating crystals comprising L-carnitine
Data Source
AI summary
Subject of the invention is a method for the production of L-carnitine, comprising the steps of (a) providing a solution comprising at least 5% (w/w) carnitine in a first solvent, wherein the carnitine is a mixture of D- and L-carnitine, (b) optionally seeding the solution with L-carnitine crystals, (c) adding an second solvent, in which the L-carnitine is not soluble or has a low solubility, (d) isolating crystals comprising L-carnitine.